Skip to content
easybpt
Browse topics

Haematology

Tumour lysis syndrome

Cairo-Bishop laboratory and clinical TLS, who is high risk (Burkitt, ALL, bulky lymphoma, venetoclax in CLL), prophylaxis with fluids plus allopurinol or rasburicase, G6PD checks, treating hyperkalaemia and hypocalcaemia safely, and when to dialyse.

Tier 1Condition

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions9 flashcards

At a glance

  • Tumour lysis syndrome (TLS) is rapid tumour cell death releasing potassium, phosphate and nucleic acids (metabolised to uric acid) faster than the kidneys can clear them.
  • It usually starts 12 to 72 hours after treatment begins, but bulky, fast-growing tumours can lyse spontaneously before treatment.
  • The danger is hyperkalaemic arrhythmia and AKI from urate and calcium phosphate crystals.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions9 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Turnstile bot check on sign-in and signed-out feedback

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.